MPZL2 anticorps (AA 61-160) (AbBy Fluor® 350)

N° du produit ABIN1389147

Détail du produit anti-MPZL2 anticorps (AbBy Fluor® 350)

Antigène: MPZL2 (Myelin Protein Zero-Like 2 (MPZL2))

Épitope: AA 61-160

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MPZL2 est conjugé à/à la AbBy Fluor® 350

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human MPZL2/EVA1

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur MPZL2

Antigène: MPZL2 (Myelin Protein Zero-Like 2 (MPZL2))

Autre désignation: MPZL2/EVA1 (MPZL2 Produits)

Synonymes: anticorps cb837, anticorps eva1, anticorps mpzl2, anticorps wu:fb07b02, anticorps EVA1, anticorps EVA, anticorps Eva, anticorps Eva1, anticorps myelin protein zero-like 2b, anticorps myelin protein zero like 2, anticorps myelin protein zero-like 2, anticorps mpzl2b, anticorps MPZL2, anticorps Mpzl2

Sujet:

Synonyms: Epithelial V like antigen 1, epithelial V-like antigen, EVA, EVA1, MPZL2, MPZL2 myelin protein zero like 2, myelin protein zero-like 2, Myelin protein zero like protein 2, MPZL2_HUMAN.

Background: Thymus development depends on a complex series of interactions between thymocytes and the stromal component of the organ. Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis. It is highly homologous to the myelin protein zero and, in thymus-derived epithelial cell lines, is poorly soluble in nonionic detergents, strongly suggesting an association to the cytoskeleton. Its capacity to mediate cell adhesion through a homophilic interaction and its selective regulation by T cell maturation might imply the participation of EVA in the earliest phases of thymus organogenesis. The protein bears a characteristic V-type domain and two potential N-glycosylation sites in the extracellular domain, a putative serine phosphorylation site for casein kinase 2 is also present in the cytoplasmic tail. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008].